These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15047089)

  • 21. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selected social-psychological characteristics of a sample of Israeli cancer patients: facts and implications.
    Baider L; Sarell M; Edelstein EL
    Isr J Med Sci; 1982 Feb; 18(2):259-65. PubMed ID: 7068357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rupture and repair of the couple's communal body with prostate cancer.
    Fergus KD
    Fam Syst Health; 2011 Jun; 29(2):95-113. PubMed ID: 21517177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan.
    Hachiya T; Akakura K; Saito S; Shinohara N; Sato K; Harada M; Kato T; Okada K
    BJU Int; 2005 Mar; 95(4):534-40. PubMed ID: 15705075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ; Malcolm JB; Derweesh IH; Womack JH; Kincade MC; Mancini JG; Ogles ML; Lamar KD; Patterson AL; Wake RW
    BJU Int; 2008 Jul; 102(1):39-43. PubMed ID: 18294309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer.
    Abrahamsson PA; Anderson J; Boccon-Gibod L; Schulman C; Studer UE; Wirth M
    Eur Urol; 2005 Dec; 48(6):900-5. PubMed ID: 16257109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The correlation between coping strategies, doctor-patient/spouse relationships and psychological distress among women cancer patients and their spouses.
    Gilbar O; Zusman A
    Psychooncology; 2007 Nov; 16(11):1010-8. PubMed ID: 17345559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of hearing impairment in older people on the spouse.
    Scarinci N; Worrall L; Hickson L
    Int J Audiol; 2008 Mar; 47(3):141-51. PubMed ID: 18307094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychosocial adjustment of men during the first year of prostate cancer.
    Ezer H; Chachamovich JR; Saad F; Aprikian A; Souhami L
    Cancer Nurs; 2012; 35(2):141-7. PubMed ID: 21760494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Men, culture and hegemonic masculinity: understanding the experience of prostate cancer.
    Wall D; Kristjanson L
    Nurs Inq; 2005 Jun; 12(2):87-97. PubMed ID: 15892724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
    Ulloa EW; Salup R; Patterson SG; Jacobsen PB
    Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary hormonal therapy for advanced prostate cancer.
    Lam JS; Leppert JT; Vemulapalli SN; Shvarts O; Belldegrun AS
    J Urol; 2006 Jan; 175(1):27-34. PubMed ID: 16406864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of the urologist and nurse from the perspective of patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue therapy.
    Lebret T; Bouregba A
    BJU Int; 2008 Nov; 102(10):1419-24. PubMed ID: 18549431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Male sexuality in theory and practice.
    Kelly D
    Nurs Clin North Am; 2004 Jun; 39(2):341-56. PubMed ID: 15159184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
    Singh H; Maskarinec G; Shumay DM
    Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer.
    Ott C; Fulton MK
    J Am Acad Nurse Pract; 2005 Mar; 17(3):113-22. PubMed ID: 15748224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the meaning of social well-being at the end of life.
    Prince-Paul M
    Oncol Nurs Forum; 2008 May; 35(3):365-71. PubMed ID: 18467287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying problems faced by spouses and partners of patients with prostate cancer.
    Hawes S; Malcarne V; Ko C; Sadler G; Banthuia R; Sherman S; Varni J; Schmidt J
    Oncol Nurs Forum; 2006 Jul; 33(4):807-14. PubMed ID: 16858462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891.
    Studer UE; Whelan P; Albrecht W; Casselman J; de Reijke T; Hauri D; Loidl W; Isorna S; Sundaram SK; Debois M; Collette L
    J Clin Oncol; 2006 Apr; 24(12):1868-76. PubMed ID: 16622261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological adjustment of survivors of localised prostate cancer: investigating the role of dyadic adjustment, cognitive appraisal and coping style.
    Wootten AC; Burney S; Foroudi F; Frydenberg M; Coleman G; Ng KT
    Psychooncology; 2007 Nov; 16(11):994-1002. PubMed ID: 17278153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.